Tag: Competition

Displaying 61 - 80 of 3536 results.

Pages

The Federal Trade Commission has announced an agenda for its upcoming workshop in Washington, DC regarding the impact of certificates of public advantage, also known as COPAs, on prices, quality, access, and innovation for healthcare services.
Canon Inc. and Toshiba Corporation have agreed to settle Federal Trade Commission charges that the companies violated the premerger notification and waiting period requirements of the Hart-Scott-Rodino Act, or HSR Act, when Canon acquired Toshiba Medical Systems Corporation from Toshiba in 2016.
WHAT:The Federal Trade Commission will host the 14th and final session of its Hearings on Competition and Consumer Protection in the 21st Century.WHEN: Wednesday, June 12, 8:30 a.m. - 5:00 p.m.WHERE:Mike and Josie Harper Center, Hixson-Lied Auditorium
The Federal Trade Commission is modernizing the process for filing agreements under the Medicare Prescription Drug, Modernization, and Improvements Act of 2003, or MMA, by requiring electronic filing instead of hard-copy submission. Starting June 17, 2019, MMA filings should be submitted to both...
The Federal Trade Commission staff has submitted a comment to the Department of Health & Human Services’ Office of the National Coordinator for Health Information Technology, or ONC, regarding ONC’s proposed rule on “information blocking.”
The Federal Trade Commission announced the agenda for the 14th session of its Hearings Initiative. This session, at Creighton University in Omaha, Nebraska on June 12, 2019, will conclude the FTC’s Hearings on Competition and Consumer Protection in the 21st Century.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that the acquisition by Tronox Limited of competitor Cristal would violate the antitrust laws by significantly reducing competition for chloride process titanium dioxide in the United States...
Last week, Bureau of Competition staff published a report on filings received in fiscal year (FY) 2016 under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA), the thirteenth such report since the MMA took effect in 2004.
A new Federal Trade Commission staff report found that, despite a considerable increase in the total number of final Hatch-Waxman patent settlements in FY 2016, significantly fewer settlements included the types of reverse payments that are likely to be anticompetitive.
Federal Trade Commission Bureau of Competition Director Bruce Hoffman issued this statement regarding the U.S. District Court for the Northern District of California’s ruling yesterday that Qualcomm Inc.’s licensing practices relating to its modem chips violate Sections 1 and 2 of the Sherman Act...
At its annual conference, the International Competition Network (ICN) established a Framework on Competition Agency Procedures (CAP) that reflects the commitment by its participants to uphold fundamental procedural fairness principles and adopted Recommended Practices for Investigative Process that...

Pages